Underlying mechanisms for LTF inactivation and its functional analysis in nasopharyngeal carcinoma cell lines

Journal of Cellular Biochemistry

Volumn 112, Issue 7, 2011, Pages 1832-1843

  Zhang, Hejun ^a   Feng, Xiangling ^a   Liu, Weidong ^a   Jiang, Xingjun ^b   Shan, Wenjiao ^a   Huang, Chengan ^c   Yi, Hongmei ^a   Zhu, Bin ^a   Zhou, Wen ^a   Wang, Lei ^a   Liu, Chunmei ^a   Zhang, Lihua ^a   Jia, Wenting ^a   Huang, Wei ^a   Li, Guifei ^a   Shi, Jia ^a   Wanggou, Siyi ^b   Yao, Kaitai ^a,d   Ren, Caiping ^a  

^a Central South University   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c GUILIN MEDICAL UNIVERSITY   (China)

^d SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Gene function; Gene mutation; Hypermethylation; Inactivation; Lactoferrin; Nasopharyngeal carcinoma; Transfection; Tumor suppressor gene

Indexed keywords

LACTOFERRIN; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; CANCER CELL CULTURE; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL GROWTH; COLONY FORMING CELL; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE INACTIVATION; GENE MUTATION; GENETIC TRANSFECTION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN METHYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RHINOPHARYNGITIS; SINGLE STRAND CONFORMATION POLYMORPHISM;

ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; CELL PROLIFERATION; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; FEMALE; G1 PHASE; HUMANS; LACTOFERRIN; LOSS OF HETEROZYGOSITY; MALE; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; NASOPHARYNGEAL NEOPLASMS; NEOPLASM TRANSPLANTATION; PROMOTER REGIONS, GENETIC; RECOMBINANT PROTEINS; TRANSCRIPTION, GENETIC; TUMOR BURDEN;

EID: 80051496128     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23101     Document Type: Review

References (40)

1. Artym J. 2006. Antitumor and chemopreventive activity of lactoferrin. Postepy Hig Med Dosw 60:352-369.
2. Bezault J, Bhimani R, Wiprovnick J, Furmanski P. 1994. Human lactoferrin inhibits growth of solid tumors and development of experimental metastases in mice. Cancer Res 54:2310-2312. (Pubitemid 24138715)
3. Chan AS, To KF, Lo KW, Mak KF, Pak W, Chiu B, Tse GM, Ding M, Li X, Lee JC, Huang DP. 2000. High frequency of chromosome 3p deletion in histologically normal nasopharyngeal epithelia from southern Chinese. Cancer Res 60:5365-5370.
4. Chen YJ, Ko JY, Chen PJ, Shu CH, Hsu MT, Tsai SF, Lin CH. 1999., Chromosomal aberrations in nasopharyngeal carcinoma analyzed by comparative genomic hybridization. Genes Chromosomes Cancer 25:169-175.
5. Cheng Y, Poulos NE, Lung ML, Hampton G, Ou B, Lerman MI, Stanbridge EJ. 1998. Functional evidence for a nasopharyngeal carcinoma tumor suppressor gene that maps at chromosome 3p21.3. Proc Natl Acad Sci USA 95:3042-3047. (Pubitemid 28135851)
6. Chow LS, Lo KW, Kwong J, To KF, Tsang KS, Lam CW, Dammann R, Huang DP. 2004. RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma. Int J Cancer 109:839-847. (Pubitemid 38500740)
7. Damiens E, El YI, Mazurier J, Duthille I, Spik G, Boilly-Marer Y. 1999. Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells. J Cell Biochem 74:486-498. (Pubitemid 29344898)
8. Fang Y, Guan X, Guo Y, Sham J, Deng M, Liang Q, Li H, Zhang H, Zhou H, Trent J. 2001. Analysis of genetic alterations in primary nasopharyngeal carcinoma by comparative genomic hybridization. Genes Chromosomes Cancer 30:254-260. (Pubitemid 32126201)
9. Finkbeiner WE, Carrier SD, Teresi CE. 1993. Reverse transcription- polymerase chain reaction (RT-PCR) phenotypic analysis of cell cultures of human tracheal epithelium, tracheobronchial glands, and lung carcinomas. Am J Respir Cell Mol Biol 9:547-556. (Pubitemid 2007529)
10. Fujita K, Matsuda E, Sekine K, Iigo M, Tsuda H. 2004. Lactoferrin enhances Fas expression and apoptosis in the colon mucosa of azoxymethane-treated rats. Carcinogenesis 25:1961-1966. (Pubitemid 39405916)
11. He J, Furmanski P. 1995. Sequence specificity and transcriptional activation in the binding of lactoferrin to DNA. Nature 373:721-724.
12. Hui AB, Lo KW, Leung SF, Teo P, Fung MK, To KF, Wong N, Choi PH, Lee JC, Huang DP. 1999. Detection of recurrent chromosomal gains and losses in primary nasopharyngeal carcinoma by comparative genomic hybridization. Int J Cancer 82:498-503. (Pubitemid 29343447)
13. Iigo M, Kuhara T, Ushida Y, Sekine K, Moore MA, Tsuda H. 1999. Inhibitory effects of bovine latoferrin on colon carcinoma 26 lung metastasis in mice. Clin Exp Metastasis 17:35-40. (Pubitemid 29284562)
14. Iijima H, Tomizawa Y, Iwasaki Y, Sato K, Sunaga N, Dobashi K, Saito R, Nakajima T, Minna JD, Mori M. 2006. Genetic and epigenetic inactivation of LTF gene at 3p21.3 in lung cancers. Int J Cancer 118:797-801. (Pubitemid 43157654)
15. Kubota T. 1994. Metastatic models of human cancer xenografted in the nude mouse: The importance of orthotopic transplantation. J Cell Biochem 56(1): 4-8. (Pubitemid 24288103)
16. Lee JY, Eom EM, Kim DS, Ha-Lee YM, Lee DH. 2003. Analysis of gene expression profiles of gastric normal and cancer tissues by SAGE. Genomics 82:78-85. (Pubitemid 36693922)
17. Lin TY, Chiou SH, Chen M, Kuo CD. 2005. Human lactoferrin exerts bidirectional actions on PC12 cell survival via ERK1/2 pathway. Biochem Biophys Res Commun 337(1): 330-336. (Pubitemid 41393798)
18. Liu XQ, Chen HK, Zhang XS, Pan ZG, Li A, Feng QS, Long QX, Wang XZ, Zeng YX. 2003. Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma. Int J Cancer 106:60-65. (Pubitemid 36750388)
19. McKeown ST, Lundy FT, Nelson J, Lockhart D, Irwin CR, Cowan CG, Marley JJ. 2006. The cytotoxic effects of human neutrophil peptide-1 (HNP1) and lactoferrin on oral squamous cell carcinoma (OSCC) in vitro. Oral Oncol 42:685-690. (Pubitemid 44094234)
20. Oh SM, Hahm DH, Kim IH, Choi SY. 2001. Human neutrophil lactoferrin trans-activates the matrix metalloproteinase 1 gene through stress-activated MAPK signaling modules. J Biol Chem 276:42575-42579.
21. Oh SM, Pyo CW, Kim Y, Choi SY. 2004. Neutrophil lactoferrin upregulates the human p53 gene through induction of NF-kappaB activation cascade., Oncogene 23:8282-8291. (Pubitemid 39531839)
22. Penco S, Caligo MA, Cipollini G, Bevilacqua G, Garré C. 1999. Lactoferrin expression in human breast cancer. Cancer Biochem Biophys 17:163-178. (Pubitemid 29475256)
23. Peng D, Ren CP, Yi HM, Zhou L, Yang XY, Li H, Yao KT. 2006. Genetic and epigenetic alterations of DLC-1, a candidate tumor suppressor gene, in nasopharyngeal carcinoma. Acta Biochim Biophys Sin 38(5): 349-355.
24. Qiu GH, Tan LK, Loh KS, Lim CY, Srivastava G, Tsai ST, Tsao SW, Tao Q. 2004., The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma., Oncogene 23:4793-4806. (Pubitemid 38859468)
25. Shaheduzzaman S, Vishwanath A, Furusato B, Cullen J, Chen Y, Bañez L, Nau M, Ravindranath L, Kim KH, Mohammed A, et al. 2007. Silencing of latotransferrin expression by methylation in prostate cancer progression. Cancer Biol Ther 6:1088-1095. (Pubitemid 351574961)
26. Son HJ, Lee SH, Choi SY. 2006. Human lactoferrin controls the level of retinoblastoma protein and its activity. Biochem Cell Biol 84:345-350.
27. Stokes K, Alston-Mills B, Teng C. 2004. Estrogen response element and the promoter context of the human and mouse lactoferrin genes influence estrogen receptor alpha-mediated transactivation activity in mammary gland cells. J Mol Endocrinol 33(2): 315-334. (Pubitemid 39429561)
28. Teng CT. 1999. Regulation of lactoferrin gene expression by estrogen and epidermal growth factor: Molecular mechanism. Cell Biochem Biophys 31(1): 49-64. (Pubitemid 129555675)
29. Teng CT, Gladwell W. 2006. Single nucleotide polymorphisms (SNPs) in human lactoferrin gene. Biochem Cell Biol 84:381-384. (Pubitemid 44341315)
30. Teng C, Gladwell W, Raphiou I, Liu E. 2004. Methylation and expression of the lactoferrin gene in human tissues and cancer cells. Biometals 17:317-323. (Pubitemid 38987156)
31. Tuccari G, Giuffrè G, Crisafulli C, Barresi G. 1999. Immunohistochemical detection of lactoferrin in human astrocytomas and multiforme glioblastomas. Eur J Histochem 43:317-322. (Pubitemid 30052189)
32. Van HA, Brinkley WR. 1999. Methods for in situ localization of proteins and DNA in the centromere-kinetochore complex. Methods Cell Biol 61:57-80.
33. Ward PP, Paz E, Conneely OM. 2005. Multifunctional roles of lactoferrin: A critical overview. Cell Mol Life Sci 62:2540-2548. (Pubitemid 41721229)
34. Xiao Y, Monitto CL, Minhas KM, Sidransky D. 2004. Lactoferrin downregulates G1 cyclin-dependent kinases during growth arrest of head and neck cancer cells. Clin Cancer Res 10:8683-8686. (Pubitemid 40053437)
35. Xiong W, Zeng ZY, Xia JH, Xia K, Shen SR, Li XL, Hu DX, Tan C, Xiang JJ, Zhou J, et al. 2004. A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Res 64:1972-1974. (Pubitemid 38339442)
36. Yi HM, Li H, Peng D, Zhang HJ, Wang L, Zhao M, Yao KT, Ren CP. 2006., Genetic and epigenetic alterations of LTF at 3p21.3 in nasopharyngeal carcinoma. Oncol Res 16:261-272. (Pubitemid 46568073)
37. Zhang Z, Teng CT. 2000. Estrogen receptor-related receptor alpha 1 interacts with coactivator and constitutively activates the estrogen response elements of the human lactoferrin gene. J Biol Chem 275: 20837-20846. (Pubitemid 30457677)
38. Zhou L, Jiang WH, Ren CP, Yin ZH, Feng XL, Liu WD, Tao Q, Yao KT. 2005., Frequent hypermethylation of RASSF1A and TSLC1, and high viral load of Epstein-Barr virus DNA in nasopharyngeal carcinoma and matched tumoradjacent tissues. Neoplasia 7:809-815.
39. Zhou YH, Zeng ZY, Zhang WL, Xiong W, Wu MH, Tan YX, Yi W, Xiao L, Li XL, Huang C, Cao L, Tang K, Li XY, Shen SR, Li GY. 2008. Lactotransferrin: A candidate tumor suppressor-deficient expression in human nasopharyngeal carcinoma and inhibition of NPC cell proliferation by modulating the mitogen-activated protein kinase pathway. Int J Cancer 123:2065-2072.
40. Zhou W, Feng XL, Li H, Wang L, Zhu B, Liu WD, Zhao M, Yao KT, Ren CP., 2009. Inactivation of LARS2, located at the commonly deleted region 3p21.3, by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma. Acta Biochim Biophys Sin 41:54-62.